Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.7 - $7.07 $36,450 - $95,445
-13,500 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$4.54 - $16.1 $61,290 - $217,350
13,500 New
13,500 $72,000
Q4 2020

Feb 16, 2021

SELL
$20.32 - $39.8 $189,341 - $370,856
-9,318 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$19.5 - $31.26 $181,701 - $291,280
9,318 New
9,318 $233,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $325M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.